Qingdao Huazhong Pharmaceuticals

Qingdao Huazhong Pharmaceutical is a specialized pharmaceutical company based in Qingdao, China, focusing on the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and finished dosage forms. The company is a prominent manufacturer of metabolic and cardiovascular medications, notably holding a significant market position in the production of metformin hydrochloride and various sulfonylureas. Operating from high-standard GMP-certified facilities, it supplies both the domestic Chinese market and international clients with high-quality generic drugs. Its core business revolves around providing cost-effective treatments for chronic conditions such as diabetes and hypertension through advanced chemical synthesis and oral solid dosage manufacturing.